![]() |
|
|
Vol. 285, Issue 3, 1005-1011, June 1998
Department of Anatomy and Developmental Biology, University College
London, London WC1E 6BT, England2
Follicular Xenopus oocytes possess a novel receptor
where both adenosine and ATP activate a cAMP-dependent, nonrectifying K+-current. Five compounds,
,
-methylene ATP
(
,
-meATP), 8-(p-sulfophenyl)theophylline (8-SPT),
theophylline, 2,2'-pyridylisatogen tosylate (PIT) and suramin, were
tested as antagonists of adenosine- and ATP-activated K+-currents. The descending order of activity
(pIC50 values) against adenosine responses was:
,
-meATP (6.72) = 8-SPT (6.68) > theophylline (5.32) > PIT
(4.58), whereas suramin was relatively inactive. The blocking actions
of
,
-meATP and alkylxanthine compounds were reversible with
washout, whereas blockade by PIT was irreversible. These antagonists
showed similar blocking activity against ATP responses, except for PIT
which was more effective at ATP responses than at adenosine responses.
The selectivity of antagonists was tested against cAMP-dependent
K+-currents evoked by forskolin and follicle-stimulating
hormone (FSH). 8-SPT and theophylline did not inhibit but instead
augmented forskolin and FSH responses; this augmentation may be caused
by inhibition of phosphodiesterase activity inside follicle cells. On
the other hand,
,
-MeATP and PIT inhibited forskolin and FSH responses; both compounds apparently are nonselective antagonists. Thus, only alkylxanthine derivatives (8-SPT and theophylline) were
selective antagonists of the novel adenosine/ATP receptor in
Xenopus oocytes, whereas
,
-meATP and PIT were
nonselective in their blocking actions and suramin was relatively
inactive.